-+ 0.00%
-+ 0.00%
-+ 0.00%

EU grants BioNTech-Pfizer XFG-targeted COVID shot approval for 2026-27 season

PUBT·07/29/2026 20:56:55
Listen to the news
EU grants BioNTech-Pfizer XFG-targeted COVID shot approval for 2026-27 season
  • European Commission granted EU marketing authorization for Pfizer-BioNTech’s XFG-adapted monovalent COVID-19 vaccine for the 2026-2027 season.
  • Authorization covers active immunization from 6 months of age across the EU, Iceland, Liechtenstein, Norway.
  • Companies started manufacturing at risk; shipments set to begin shortly to support seasonal rollout.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607291630OMX_____CNEWS_DE_GNW1001255058_de) on July 29, 2026, and is solely responsible for the information contained therein.